Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 267 Magnetic Resonance Spectroscopy 218 pembrolizumab 203 Carboplatin 170 Cisplatin 137 Biopsy 136 Cyclophosphamide 131 Paclitaxel 120 Nivolumab 110 Bevacizumab 104 Gemcitabine 102 Radiotherapy 85 Dexamethasone 77 Pemetrexed 75 atezolizumab 73 Fluorouracil 71 fludarabine 69 Doxorubicin 68 Leucovorin 66 Docetaxel 66 Radiation 65 Oxaliplatin 62 Rituximab 60 venetoclax 58 Prednisone 58 Cetuximab 54 durvalumab 53 Vincristine 52 Etoposide 51 130-nm albumin-bound paclitaxel 51

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Conservative Treatment × 30 days × Clear all

NCT06022159 2026-06-02

HYPOSARC

Institut Claudius Regaud

Phase 2 Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡